Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. First Quarter Revenue Performance and Detailed Segment Analysis
IDXX logo

IDEXX Revenues Soar 14% to $1.14 Billion as Pet Diagnostic Demand Hits Record Highs

IDXX8-KFiling Date: 5/5/2026
IDEXX Laboratories, Inc.
Description

What this story covers

IDEXX Laboratories delivered a powerful Q1 2026, reaching $1.14 billion in revenue driven by double-digit growth in companion animal diagnostics. With record free cash flow and raised full-year guidance, the company demonstrates exceptional operational efficiency and market leadership.

Story snapshot

CompanyIDEXX Laboratories, Inc.
TickerIDXX
VariantStandard detailed
Duration5:04
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-055203
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in